Ranitidine
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171917This classification denotes a histamine-2 receptor antagonist with the molecular formula C19H27BiN4O10S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7AJ51I17KG, chemically known as bismuth;(E)-1-N'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine;2-hydroxypropane-1,2,3-tricarboxylate but generally known as ranitidine bismuth citrate, which bears US NIH Compound Identifier 3033887. European Medicines Agency schedules Ranitidine bismuth citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15106MIG. The term RANITIDINE is an International Non-Proprietary Name. World Health Organization schedules ranitidine in its Anatomical Therapeutic Chemical (ATC) Classification. RANITIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ranitidine under HS 29321900 and SITC 51569. As of Q4 2014, RANITIDINE remains the US FDA Preferred Term for this commodity. Ranitidine bears US NLM identifiers UMLS ID C0034665 and NCI Concept Code C29412. SMILES: CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Bi+3].
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.